[go: up one dir, main page]

FR2460669B1 - Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation - Google Patents

Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation

Info

Publication number
FR2460669B1
FR2460669B1 FR8015261A FR8015261A FR2460669B1 FR 2460669 B1 FR2460669 B1 FR 2460669B1 FR 8015261 A FR8015261 A FR 8015261A FR 8015261 A FR8015261 A FR 8015261A FR 2460669 B1 FR2460669 B1 FR 2460669B1
Authority
FR
France
Prior art keywords
rhumatism
rifamycin
joint
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8015261A
Other languages
English (en)
Other versions
FR2460669A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT24227/79A external-priority patent/IT1122095B/it
Priority claimed from IT22778/80A external-priority patent/IT1131826B/it
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of FR2460669A1 publication Critical patent/FR2460669A1/fr
Application granted granted Critical
Publication of FR2460669B1 publication Critical patent/FR2460669B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8015261A 1979-07-10 1980-07-09 Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation Expired FR2460669B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT24227/79A IT1122095B (it) 1979-07-10 1979-07-10 Metodo per la terapia dell'artrite reumatoide e formulazioni farmaceutiche idonee allo scopo
IT22778/80A IT1131826B (it) 1980-06-13 1980-06-13 Salli di rifamicana sv,loro impiego nella terapia dell'artrite reumatoide e relative composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
FR2460669A1 FR2460669A1 (fr) 1981-01-30
FR2460669B1 true FR2460669B1 (fr) 1985-11-15

Family

ID=26328265

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8015261A Expired FR2460669B1 (fr) 1979-07-10 1980-07-09 Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation

Country Status (6)

Country Link
US (1) US4312866A (fr)
DE (2) DE3026180C2 (fr)
ES (1) ES8106004A1 (fr)
FR (1) FR2460669B1 (fr)
GB (1) GB2056276B (fr)
SE (1) SE458505B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO64266B1 (ro) * 1976-06-25 1983-04-30 Institutul De Cercetari Chimico-Farmaceutice Rifamicine hidrosolubile si procedeu de preparaea a acestora
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
US4828828A (en) * 1987-07-28 1989-05-09 Trager Seymour F Method of treating degenerative joint disease by injection of meth(acrylamide) (co)-polymers
BG64021B1 (bg) * 1998-11-04 2003-10-31 КОНСТАНТИНОВА Румяна Натриева сол на 3-(4-цинамил-1-пиперазинил)-иминометил рифамицин и метод за получаването й
CA2529817C (fr) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Nouveaux agents antibacteriens
ITMI20041295A1 (it) * 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
CN101394846A (zh) * 2006-03-03 2009-03-25 活跃生物药物学有限公司 动脉粥样硬化症的治疗
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (fr) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Procédés de traitement de maladies résistantes en utilisant des macrolides contenant du triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr) * 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Formulations parentérales pour l'administration d'antibiotiques macrolides
EP2968801B1 (fr) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Procédés pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
CN104107163B (zh) * 2014-02-28 2016-05-18 江西赣南海欣药业股份有限公司 一种利福霉素钠vc药用组合物注射剂制备方法
WO2019240677A2 (fr) * 2017-03-09 2019-12-19 Bilici Namik Composition de vitamine c et de vitamine e avec rifampicine pour le traitement de toutes les plaies infectées et de tous les problèmes dermatologiques infectés ou susceptibles d'être infectés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR469021A (fr) * 1913-01-07 1914-07-22 Luigi Vittorio Nicolai Appareil pour la pulvérisation de liquides
GB924472A (en) * 1959-08-07 1963-04-24 Lepetit Spa Antibiotics prepared from rifamycin b
CA939265A (en) * 1967-11-18 1974-01-01 Yoshitaka Ikezuki Injectable compositions for alleviating the pain incurred from administrations of injections
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins

Also Published As

Publication number Publication date
SE8004965L (sv) 1981-01-11
ES493216A0 (es) 1981-07-01
ES8106004A1 (es) 1981-07-01
FR2460669A1 (fr) 1981-01-30
US4312866A (en) 1982-01-26
GB2056276A (en) 1981-03-18
SE458505B (sv) 1989-04-10
DE3026180C2 (de) 1986-02-06
GB2056276B (en) 1984-02-29
DE3026180A1 (de) 1981-01-29
DE3050802C2 (de) 1986-04-03

Similar Documents

Publication Publication Date Title
FR2460669B1 (fr) Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation
BE855032A (fr) Compositions pharmaceutiques pour opacification barytee et leur procede de preparation
BE866226A (fr) Procede pour la preparation de thymosine alpha1 et d'un analogue
MA19474A1 (fr) Procede de preparation de derives de cephalosporine et leur application a la preparation de compositions therapeutiques
BE849218A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2308355A1 (fr) Formes de posologie pharmaceutiques solides a liberation soutenue et leur procede de preparation
BE884153A (fr) Procede de preparation de compositions pharmaceutiques se desagregeant aisement
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
FR2324621A1 (fr) Procede pour la preparation d'acide 5-cyanovalerique et de ses esters
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE837294A (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2640140B1 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation
BE870219A (fr) Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs
PT64998B (fr) Procede de preparation de nouvelles compositions pharmaceutiques et compositions obtenues par ce procede
BE840944A (fr) Procede de preparation d'acides carboxy-alcane-phosphoniques et d'acides carboxy-alkyl-phosphiniques
FR2536280B1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
PT72256A (fr) Procede de preparation de compositions pharmaceutiques a base d' alpha-/2-/bis-(1-methyl ethyl) amino/ethyl/alpha-phenil 2-pyridine acetamide ou de l'un de ses sels

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse